1,261
Views
12
CrossRef citations to date
0
Altmetric
Commentary

How to determine protective immunity in the post-vaccine era

, &
Pages 903-906 | Received 18 Nov 2015, Accepted 02 Dec 2015, Published online: 13 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jun Wang, Yuyang Xu, Xiaozhen Wang, Yan Liu, Xiaoping Zhang, Jian Du, Xinren Che, Wenwen Gu, Xuechao Zhang, Wei Jiang & Yi Wang. (2022) Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China. Human Vaccines & Immunotherapeutics 18:5.
Read now

Articles from other publishers (11)

Susan E. Reef & Stanley A. Plotkin. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1025 1056.e19 .
E. Bouthry, C. Perillaud-Dubois, P. Lebraud, M.P. Soutière, L. Grangeot-Keros & C. Vauloup-Fellous. (2021) Positive predictive value of seroconversion or positive rubella IgM in diagnosis of maternal rubella infection. Journal of Clinical Virology 134, pages 104708.
Crossref
Anna R. Connell, Jeff Connell, T. Ronan Leahy & Jaythoon Hassan. (2020) Mumps Outbreaks in Vaccinated Populations—Is It Time to Re-assess the Clinical Efficacy of Vaccines?. Frontiers in Immunology 11.
Crossref
Melanie D. Swift & Amy J. Behrman. (2019) Vaccines for Health Care Personnel. Mayo Clinic Proceedings 94:10, pages 2127-2141.
Crossref
G. M. Ignatev, E. V. Atrashevskaya, L. L. Suchanova, E. S. Sidorenko & N. A. Netesova. (2019) Molecular-genetic study of the RA-27/3 strain used for production of rubella vaccine. Journal of microbiology, epidemiology and immunobiology 96:4, pages 38-46.
Crossref
O. Picone, E. Bouthry, Y. Bejaoui-Olhmann, AG Cordier, S. Nedellec, A. Letourneau, M. Carbonel, M. Brollo, L. Grangeot-Keros, JM. Ayoubi, A. Benachi, E. Rouge & C. Vauloup-Fellous. (2019) Determination of rubella virus-specific humoral and cell-mediated immunity in pregnant women with negative or equivocal rubella-specific IgG in routine screening. Journal of Clinical Virology 112, pages 27-33.
Crossref
C. Vauloup-Fellous. (2018) Standardization of rubella immunoassays. Journal of Clinical Virology 102, pages 34-38.
Crossref
Daiki Kanbayashi, Takako Kurata, Kazuo Takahashi, Tetsuo Kase & Jun Komano. (2018) A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus. Journal of Virological Methods 252, pages 86-93.
Crossref
Susan E. Reef & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines 970 1000.e18 .
Nicolas L. Gilbert, Jenny Rotondo, Janna Shapiro, Lindsey Sherrard, William D. Fraser & Brian J. Ward. (2017) Seroprevalence of rubella antibodies and determinants of susceptibility to rubella in a cohort of pregnant women in Canada, 2008–2011. Vaccine 35:23, pages 3050-3055.
Crossref
Karoliina Koivisto, Laura Puhakka, Maija Lappalainen, Soile Blomqvist, Harri Saxén & Tea Nieminen. (2017) Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. Vaccine 35:12, pages 1608-1614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.